Kuiper Pharmaceuticals Private Limited
About Kuiper Pharmaceuticals Private Limited
Data last updated:
Kuiper Pharmaceuticals Private Limited is a private limited company based in Vikasnagar, Uttarakhand, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 22 March 2022.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24290UR2022PTC013712.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajendra Rajpoot Singh and Mayank Singh Rajpoot.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vikasnagar, Uttarakhand.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.33 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹77,585 (net margin 2.7%) and EBITDA of ₹82,024 (EBITDA margin 2.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kuiper Pharmaceuticals Private Limited's registered office is in Vikasnagar, Uttarakhand.
- Registered AddressC/O Preeti Rajpoot, Opp Rto Office Mirjapur Urf Dhalipur, Vikasnagar, Uttarakhand, India – 248142
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kuiper Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kuiper Pharmaceuticals Private Limited, buy the company report.
Financials of Kuiper Pharmaceuticals Private Limited
FY 2025 filings availableKuiper Pharmaceuticals Private Limited reported revenue of ₹28.33 Lakh (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 48% in the latest year. EBITDA rose 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹82,024 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹77,585 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.9% | |||
| Net Profit Margin | 2.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Kuiper Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kuiper Pharmaceuticals Private Limited
Kuiper Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Rajpoot Singh Also directs: Three B Healthcare Limited, Rxgenius Medicare Private Limited | Director | 22 Mar 2022 | 4 Years 7 Months | Current |
| Mayank Singh Rajpoot | Director | 22 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Kuiper Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanvik Pharmaceuticals Private Limited | ₹28.57 Lakh (FY 2025) | 4.0% | Ranchi, Jharkhand, India | |||
| Kuiper Pharmaceuticals Private Limitedthis company | ₹28.33 Lakh (FY 2025) | ₹77,585 | 2.7% | 48.0% | Vikasnagar, Uttarakhand, India | |
| Arobic Remedies and Pharmaceuticals Private Limited | ₹28.32 Lakh (FY 2022) | -29.0% | Nagpur, Maharashtra, India | |||
| Mormon Pharmaceuticals Private Limited | ₹28.26 Lakh (FY 2020) | -41.0% | Amravati, Maharashtra, India | |||
| Alphard Pharmaceuticals Private Limited | ₹28.23 Lakh (FY 2022) | Panvel, Maharashtra, India | ||||
| Eshar Pharmaceuticals Private Limited | ₹28.21 Lakh (FY 2023) | 4.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Kuiper Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kuiper Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kuiper Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kuiper Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kuiper Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Mayank Singh Rajpoot was appointed as Director on 22 Mar 2022.
Frequently asked questions
Kuiper Pharmaceuticals is an active private limited company based in Vikasnagar, Uttarakhand, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 22 March 2022 (4+ years old) and is registered under CIN U24290UR2022PTC013712.
Kuiper Pharmaceuticals has 2 current directors:
- Rajendra Rajpoot Singh - Director
- Mayank Singh Rajpoot - Director
The latest financial statements of Kuiper Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Kuiper Pharmaceuticals is U24290UR2022PTC013712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kuiper Pharmaceuticals was incorporated on 22 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Kuiper Pharmaceuticals by revenue are Sanvik Pharmaceuticals Private Limited, Arobic Remedies and Pharmaceuticals Private Limited, Mormon Pharmaceuticals Private Limited, Alphard Pharmaceuticals Private Limited, Eshar Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mayank Singh Rajpoot was appointed as Director on 22 Mar 2022. Rajendra Rajpoot Singh was appointed as Director on 22 Mar 2022.
The registered office of Kuiper Pharmaceuticals is at CO Preeti Rajpoot, Opp Rto Office Mirjapur Urf Dhalipur, Vikasnagar, Uttarakhand, India – 248142.
Kuiper Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Kuiper Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.
Kuiper Pharmaceuticals can be reached at its registered office: CO Preeti Rajpoot, Opp Rto Office Mirjapur Urf Dhalipur, Vikasnagar, Uttarakhand, India – 248142.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
